Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dmitry Balyasny Reports A Massive Increase In Holding Of Boardwalk Pipeline Partners LP (BWP)

Dmitry Balyasny, the founder and manager of Balyasny Asset Management, is very bullish on Boardwalk Pipeline Partners, LP (NYSE:BWP). In a recent filing with the Securities and Exchange Commission, Balyasny Asset Management has revealed a massive increase in its stake from 167,500 to 13.80 million shares, a position which accounts for approximately 5.7% of the company’s common stock.

Dmitry Balyasny

Jim Simmons is also a huge fan of Boardwalk Pipeline Partners, LP (NYSE:BWP), having increased his fund’s stake by more than 6,000% during the 2013 fourth quarter. In its latest 13F filing, Renaissance Technologies reported ownership of 453,000 shares valued at $11.5 million. Jean-Marie Eveillard has boosted his fund’s stake by 200% during the same period, taking it to 300,000 shares reportedly worth $7,65 million.

Boardwalk Pipeline Partners, LP (NYSE:BWP) offers transportation and processing services for the natural gas industry. The company has a market cap of $3.8 billion and pays an annual dividend of $1.7 per share, which translates into a yield of 12.10%. So far in 2014, the stock has plummeted 44% to a current price of $14.21 per share. The stock is traded at a trailing Price to Earnings (P/E) ratio of 15.xx, which is significantly lower than the industry average of 41.00.

For the three months ending December 31, 2013, Boardwalk Pipeline Partners announced revenues of $312 million and earnings per share of $0.3. Analysts expect the company to register $302 million in revenues and EPS of $0.3 for the first quarter of 2014. Most brokers expect the stock to underperform.

Balyasny is also bullish on Newfield Exploration Co. (NYSE:NFX), having increased his fund’s holding of the stock by 131% during the fourth quarter of 2013. As a result, Balyasny Asset Management currently holds 4.84 million shares valued at $119 million. Balyasny is also betting big on Apple Inc. (NASDAQ:AAPL) and has taken his fund’s position to approximately 165,500 shares reportedly worth $92.8 million.

Disclosure: none.

Recommended reading:

Edward Lampert, ESL Investments Report Stake In Post Spin-off Lands’ End, Inc. (LE)

Kevin Kotler’s Broadfin Capital Reveals New Stake in Dipexium Pharmaceuticals (DPRX)

Hedge Fund News: Philippe Laffont, Michael Hintze & Stephen Mandel

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!